A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants
Clinical trial NCT03870555 · COMPLETED
Trial details
- NCT number
- NCT03870555
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2019-05-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.